A detailed history of Virtus ETF Advisers LLC transactions in Allakos Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 27,504 shares of ALLK stock, worth $27,504. This represents 0.02% of its overall portfolio holdings.

Number of Shares
27,504
Previous 29,391 6.42%
Holding current value
$27,504
Previous $80,000 57.5%
% of portfolio
0.02%
Previous 0.05%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$1.02 - $3.23 $1,924 - $6,095
-1,887 Reduced 6.42%
27,504 $34,000
Q4 2023

Feb 15, 2024

BUY
$1.72 - $3.18 $15,848 - $29,300
9,214 Added 45.67%
29,391 $80,000
Q3 2023

Nov 07, 2023

SELL
$2.13 - $5.55 $4,289 - $11,177
-2,014 Reduced 9.08%
20,177 $45,000
Q2 2023

Aug 14, 2023

BUY
$3.6 - $5.25 $27,921 - $40,719
7,756 Added 53.73%
22,191 $96,000
Q1 2023

May 15, 2023

SELL
$4.3 - $8.27 $23,847 - $45,865
-5,546 Reduced 27.76%
14,435 $64,000
Q4 2022

Feb 14, 2023

BUY
$5.97 - $8.42 $119,286 - $168,240
19,981 New
19,981 $168,000
Q2 2022

Aug 12, 2022

SELL
$2.6 - $6.14 $4,945 - $11,678
-1,902 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$5.08 - $9.81 $568 - $1,098
-112 Reduced 5.56%
1,902 $11,000
Q4 2021

Feb 14, 2022

SELL
$8.55 - $111.89 $2,787 - $36,476
-326 Reduced 13.93%
2,014 $20,000
Q3 2021

Nov 15, 2021

SELL
$76.53 - $110.43 $9,336 - $13,472
-122 Reduced 4.96%
2,340 $248,000
Q2 2021

Aug 10, 2021

SELL
$85.37 - $114.1 $1,536 - $2,053
-18 Reduced 0.73%
2,462 $210,000
Q1 2021

May 17, 2021

BUY
$109.73 - $153.66 $4,169 - $5,839
38 Added 1.56%
2,480 $285,000
Q4 2020

Feb 12, 2021

SELL
$79.58 - $152.45 $167,834 - $321,517
-2,109 Reduced 46.34%
2,442 $342,000
Q3 2020

Nov 13, 2020

SELL
$66.43 - $90.99 $40,389 - $55,321
-608 Reduced 11.79%
4,551 $371,000
Q2 2020

Aug 05, 2020

BUY
$44.04 - $80.69 $98,253 - $180,019
2,231 Added 76.2%
5,159 $371,000
Q1 2020

May 14, 2020

SELL
$44.49 - $93.39 $18,774 - $39,410
-422 Reduced 12.6%
2,928 $130,000
Q4 2019

Feb 13, 2020

SELL
$66.49 - $137.73 $176,397 - $365,397
-2,653 Reduced 44.19%
3,350 $319,000
Q3 2019

Nov 12, 2019

SELL
$31.0 - $89.73 $10,385 - $30,059
-335 Reduced 5.29%
6,003 $472,000
Q2 2019

Aug 13, 2019

BUY
$36.0 - $44.73 $68,436 - $85,031
1,901 Added 42.84%
6,338 $275,000
Q1 2019

May 14, 2019

SELL
$33.79 - $51.99 $19,496 - $29,998
-577 Reduced 11.51%
4,437 $180,000
Q4 2018

Feb 05, 2019

BUY
$31.59 - $62.65 $158,392 - $314,127
5,014 New
5,014 $262,000

Others Institutions Holding ALLK

About Allakos Inc.


  • Ticker ALLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,726,096
  • Market Cap $84.7M
  • Description
  • Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...
More about ALLK
Track This Portfolio

Track Virtus ETF Advisers LLC Portfolio

Follow Virtus ETF Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.